Experience with rufinamide in a pediatric population: A single center's experience

Pediatric Neurology

Volumn 43, Issue 3, 2010, Pages 155-158

  Vendrame, Martina ^a   Loddenkemper, Tobias ^a,b   Gooty, Vasu D ^a,b   Takeoka, Masanori ^a,b   Rotenberg, Alexander ^a,b   Bergin, Ann M ^a,b   Eksioglu, Yaman Z ^a,b   Poduri, Annapurna ^a,b   Duffy, Frank H ^a,b   Libenson, Mark ^a,b   Bourgeois, Blaise F ^a,b   Kothare, Sanjeev V ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RUFINAMIDE;

ADOLESCENT; ADULT; ANOREXIA; ARTICLE; CHILD; CONTROLLED STUDY; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GRAND MAL SEIZURE; HEADACHE; HUMAN; INFANTILE SPASM; LENNOX GASTAUT SYNDROME; MAJOR CLINICAL STUDY; MALE; MYOCLONUS SEIZURE; NAUSEA; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; SCHOOL CHILD; TONIC CLONIC SEIZURE; TREATMENT RESPONSE; VISUAL DISORDER; VISUAL IMPAIRMENT; VOMITING; WEST SYNDROME;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMANS; INFANT; MALE; PEDIATRICS; RETROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME; TRIAZOLES; YOUNG ADULT;

EID: 77955534377     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2010.04.003     Document Type: Article

References (12)

1. E. Perucca, J. Cloyd, D. Critchley, and E. Fuseau Rufinamide: Clinical pharmacokinetics and concentration-response relationships in patients with epilepsy Epilepsia 49 2008 1123 1141
2. A. Cheng-Hakimian, G.D. Anderson, and J.W. Miller Rufinamide: Pharmacology, clinical trials, and role in clinical practice Int J Clin Pract 60 2006 1497 1501
3. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised classification of epilepsies and epileptic syndromes Epilepsia 30 1989 389 399
4. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised clinical and electroencephalographic classification of epileptic seizures Epilepsia 22 1981 489 501
5. S. Palhagen, R. Canger, O. Henriksen, J.A. van Parys, M.E. Riviere, and M.A. Karolchyk Rufinamide: A double-blind, placebo-controlled proof of principle trial in patients with epilepsy Epilepsy Res 43 2001 115 124
6. V. Biton, S. Schachter, and C.A.S. Perdomo Efficacy and safety of adjunctive rufinamide in patients with inadequately controlled primary generalized tonic-clonic seizures Epilepsia 46 2005 206
7. T. Glauser, G. Kluger, R. Sachdeo, G. Krauss, C. Perdomo, and S. Arroyo Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome Neurology 70 2008 1950 1958
8. G. Kluger, G. Kurlemann, and E. Haberlandt Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: First European experience Epilepsy Behav 14 2009 491 495
9. M.J. Brodie, W.E. Rosenfeld, and B. Vazquez Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: A randomized placebo-controlled trial Epilepsia 50 2009 1899 1909
10. J.W. Wheless, and B. Vazquez Rufinamide: A novel broad-spectrum antiepileptic drug Epilepsy Currents 10 2010 1 6
11. S. Arroyo Rufinamide Neurotherapeutics 4 2007 155 162
12. T.A. Glauser, A. Arzimanoglou, and M. Litzinger Efficacy and safety of rufinamide as adjunctive therapy for inadequately controlled partial seizures in pediatric patients Epilepsia 46 Suppl. 8 2005 194 195